🔥 RAD-140 Research Spotlight

Why This Selective Androgen-Receptor Modulator Attracted Scientific Attention

RAD-140, also known as vosilasarm or Testolone, is an experimental nonsteroidal selective androgen-receptor modulator. It was designed to investigate whether researchers could separate desirable anabolic signaling from some of the effects associated with traditional androgens.

What makes RAD-140 especially interesting is its activity across several distinct areas of research:

• Androgen-receptor activation

• Skeletal-muscle and bone signaling

• Tissue-selective anabolic activity

• Neuronal survival

• Hormone-responsive breast-cancer models

These characteristics have made RAD-140 one of the most widely recognized compounds in SARM research.

⚙️ How RAD-140 Works

RAD-140 binds to the androgen receptor, the same receptor involved in many of testosterone’s biological effects.

Unlike testosterone, RAD-140 has a nonsteroidal chemical structure. Preclinical experiments suggest that its activity differs depending on the tissue being studied.

This concept is known as tissue selectivity. Researchers are interested in compounds that produce comparatively strong anabolic signaling in muscle and bone while behaving differently in reproductive tissues.

RAD-140 is not completely selective for muscle, but its distinctive activity profile made it an interesting candidate for continued investigation.

🔬 Preclinical Anabolic Findings

A 2011 preclinical study examined RAD-140 using receptor assays, rats, and nonhuman primates.

Researchers reported:

• Strong androgen-receptor activity

• Anabolic responses in animal muscle models

• Different activity across muscle, prostate, and seminal-vesicle tissues

• Changes in lean-tissue measurements in nonhuman primates

• Oral activity under the studied experimental conditions

The research demonstrated that RAD-140 was biologically active and capable of producing tissue-dependent responses.

These findings helped establish RAD-140 as an important compound for studying whether nonsteroidal androgen-receptor modulators could provide a different pharmacological profile from testosterone.

🧬 Why Tissue Selectivity Matters

Traditional androgens activate receptors throughout the body. SARM research attempts to develop compounds that produce different levels of receptor activity depending on the tissue and biological environment.

In early RAD-140 research, scientists observed:

• Anabolic activity in muscle-related models

• Comparatively different effects in reproductive tissues

• Partial agonist or antagonist-like behavior in certain experimental settings

• Activity that varied according to the tissue being examined

This does not mean RAD-140 acts exclusively in muscle. Instead, it demonstrates why researchers consider it an interesting example of tissue-dependent androgen-receptor signaling.

🧠 Neuroprotection Research

RAD-140 has also produced notable findings outside traditional anabolic research.

A study involving cultured neurons and an injured-rat model investigated whether RAD-140 could influence neuronal survival through androgen-receptor-dependent pathways.

Researchers reported:

• Increased survival of cultured neurons under certain conditions

• Changes in cellular signaling associated with neuroprotection

• Reduced neuronal damage in an experimental rat model

• Evidence that androgen-receptor activity contributed to the observed response

This expanded scientific interest in RAD-140 beyond muscle and bone. These findings remain preclinical and do not establish neurological benefits in humans.

🎗️ Breast-Cancer Research

RAD-140 has also been studied under the name vosilasarm in androgen-receptor-positive breast-cancer models.

Preclinical research suggested that RAD-140 could inhibit the growth of certain androgen-receptor-positive and estrogen-receptor-positive breast-cancer models through a mechanism distinct from traditional anti-estrogen therapies.

That work eventually led to a small first-in-human Phase I oncology study. This research focused on safety, pharmacokinetics, and possible antitumor activity—not physique or performance enhancement.

The oncology program demonstrates that RAD-140 has been investigated as a genuine experimental pharmaceutical compound rather than existing solely within the supplement market.

📊 RAD-140 Research at a Glance

Research area

What has been observed

Androgen receptor

Strong receptor-binding and agonist activity

Muscle models

Anabolic responses in preclinical research

Tissue selectivity

Different activity across muscle and reproductive tissues

Nonhuman primates

Changes in lean-tissue measurements

Neuronal models

Neuroprotective signals in cells and injured rodents

Breast-cancer models

Activity in certain hormone-responsive models

Human research

Limited Phase I oncology investigation

Regulatory status

Investigational and not FDA-approved

🔍 What Makes RAD-140 Scientifically Distinctive?

RAD-140 stands out because it has been examined across several areas rather than in only one isolated experiment.

Its research profile includes:

• A defined chemical structure

• Characterized androgen-receptor activity

• Animal anabolic data

• Nonhuman-primate research

• Neurological experiments

• Cancer-model research

• Limited early-stage clinical investigation

Together, these findings make RAD-140 a scientifically notable SARM and an interesting subject for continued controlled research.

⚠️ Important Research Context

The available evidence does not establish RAD-140 as safe or effective for building muscle, improving strength, accelerating recovery, or changing body composition in humans.

Animal tissue selectivity does not guarantee the same selectivity in people. Limited clinical research has also identified liver-enzyme changes and other adverse events requiring further investigation.

No clinically validated bodybuilding dose, cycle, stack, or post-cycle protocol exists.

⭐ Research Verdict

RAD-140 is one of the more extensively characterized experimental SARMs. It has demonstrated strong androgen-receptor activity, anabolic effects in animal models, tissue-dependent signaling, neuroprotective findings in preclinical experiments, and activity in certain breast-cancer models.

The research does not establish human physique-enhancement benefits, but it clearly demonstrates why RAD-140 continues to attract scientific attention.

Its combination of anabolic signaling, tissue selectivity, oral activity in experimental models, and research across multiple biological systems makes RAD-140 a compelling subject for further laboratory investigation.

Learn more about RAD-140

Affiliate disclosure: The link above is a referral link. I may receive a commission if it is used, at no additional cost to the purchaser.

For laboratory-research purposes only. Not for human or veterinary use.

This material is provided solely for general educational discussion of research. It is not medical advice, does not provide dosing, cycle, stacking, or post-cycle instructions, does not recommend personal use or self-experimentation, and does not claim that RAD-140 can diagnose, treat, cure, or prevent any disease.